Cargando…
Almost Complete Response with a Single Administration (225)Ac-DOTATATE in a Patient with a Metastatic Neuroendocrine Tumor of Unknown Primary
Neuroendocrine tumors (NETs) are being seen increasingly frequently, and the only known curative treatment method is surgical resection. Peptide receptor radionuclide therapy (PRRT) is a treatment option that the most contributes to progression-free survival and overall survival in metastatic cases....
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246299/ https://www.ncbi.nlm.nih.gov/pubmed/35771003 http://dx.doi.org/10.4274/mirt.galenos.2022.64497 |